Miraç Aysen Ünsal1, Nüket Yıldız Manukyan2, Nihal IŞik3, Güher Saruhan Dİreskenelİ4. 1. Neurology Department, Sultan Abdülhamid Han Training Hospital, İstanbul, Turkey. 2. Neurology Department, Fatih Sultan Mehmet Training Hospital, İstanbul, Turkey. 3. Neurology Department, Okan University School of Medicine, İstanbul, Turkey. 4. Physiology Department, İstanbul University School of Medicine, İstanbul, Turkey.
Abstract
INTRODUCTION: The T244I variant of the IL-7RA gene, rs6897932, is one of the first polymorphisms found to be associated with the development of multiple sclerosis (MS). Although several studies provided evidence for the association of MS and this variant, other studies could not confirm this result. These inconsistent results suggest that the role of this polymorphism in the development of disease is associated with ethnicity. METHODS: We investigated rs6897932 polymorphisms in a large cohort of patients with MS and healthy controls in a turkish population. RESULTS: In our study, there were no significant differences in genotype frequencies in the IL-7RA rs6897932 polymorphism and no significant difference between C and T alleles in patients with MS and controls. CONCLUSION: This study is the first to evaluate the risk of the rs6897932 polymorphism in turkish patients with MS. Copyright:
INTRODUCTION: The T244I variant of the IL-7RA gene, rs6897932, is one of the first polymorphisms found to be associated with the development of multiple sclerosis (MS). Although several studies provided evidence for the association of MS and this variant, other studies could not confirm this result. These inconsistent results suggest that the role of this polymorphism in the development of disease is associated with ethnicity. METHODS: We investigated rs6897932 polymorphisms in a large cohort of patients with MS and healthy controls in a turkish population. RESULTS: In our study, there were no significant differences in genotype frequencies in the IL-7RA rs6897932 polymorphism and no significant difference between C and T alleles in patients with MS and controls. CONCLUSION: This study is the first to evaluate the risk of the rs6897932 polymorphism in turkish patients with MS. Copyright:
Authors: Hans J Hartling; Cecilie J Sørensen; Andreas S Rigas; Kristoffer S Burgdorf; Susanne D Nielsen; Ole B Pedersen; Mikkel S Petersen; Erik Sørensen; Sebastian Kotzé; Lise W Thørner; Henrik Hjalgrim; Christian Erikstrup; Henrik Ullum Journal: APMIS Date: 2014-11-25 Impact factor: 3.205
Authors: Z Zhang; K Duvefelt; F Svensson; T Masterman; G Jonasdottir; H Salter; T Emahazion; D Hellgren; G Falk; T Olsson; J Hillert; M Anvret Journal: Genes Immun Date: 2005-03 Impact factor: 2.676
Authors: B Broux; N Hellings; K Venken; J-L Rummens; K Hensen; B Van Wijmeersch; P Stinissen Journal: Genes Immun Date: 2010-01-14 Impact factor: 2.676
Authors: David A Hafler; Alastair Compston; Stephen Sawcer; Eric S Lander; Mark J Daly; Philip L De Jager; Paul I W de Bakker; Stacey B Gabriel; Daniel B Mirel; Adrian J Ivinson; Margaret A Pericak-Vance; Simon G Gregory; John D Rioux; Jacob L McCauley; Jonathan L Haines; Lisa F Barcellos; Bruce Cree; Jorge R Oksenberg; Stephen L Hauser Journal: N Engl J Med Date: 2007-07-29 Impact factor: 91.245
Authors: Simon G Gregory; Silke Schmidt; Puneet Seth; Jorge R Oksenberg; John Hart; Angela Prokop; Stacy J Caillier; Maria Ban; An Goris; Lisa F Barcellos; Robin Lincoln; Jacob L McCauley; Stephen J Sawcer; D A S Compston; Benedicte Dubois; Stephen L Hauser; Mariano A Garcia-Blanco; Margaret A Pericak-Vance; Jonathan L Haines Journal: Nat Genet Date: 2007-07-29 Impact factor: 38.330